Themis Medicare Limited (THEMISMED.NS)
INR 274.7
(1.42%)
INR 274.7
(1.42%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 2.42 Billion INR | -36.26% |
| 2022 | 2.35 Billion INR | -2.75% |
| 2021 | 2.42 Billion INR | 61.6% |
| 2020 | 1.5 Billion INR | 9.82% |
| 2019 | 1.36 Billion INR | 19.68% |
| 2018 | 1.14 Billion INR | -16.31% |
| 2017 | 1.36 Billion INR | -16.15% |
| 2016 | 1.62 Billion INR | 11.92% |
| 2015 | 1.45 Billion INR | 32.79% |
| 2014 | 1.09 Billion INR | 0.64% |
| 2013 | 1.08 Billion INR | 18.5% |
| 2012 | 918.39 Million INR | 699.76% |
| 2011 | 114.83 Million INR | -49.65% |
| 2010 | 228.09 Million INR | -28.61% |
| 2009 | 319.51 Million INR | 382.26% |
| 2008 | 66.25 Million INR | -78.84% |
| 2007 | 313.14 Million INR | 27.69% |
| 2006 | 245.24 Million INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 577.22 Million INR | 74.52% |
| 2024 Q2 | 753.75 Million INR | -15.89% |
| 2023 Q2 | 628.43 Million INR | -7.01% |
| 2023 Q3 | 560.3 Million INR | -10.84% |
| 2023 Q4 | 330.75 Million INR | -40.97% |
| 2023 FY | 1.5 Billion INR | -36.26% |
| 2023 Q1 | 675.78 Million INR | 29.2% |
| 2022 Q1 | 648.26 Million INR | 31.77% |
| 2022 Q2 | 634.81 Million INR | -2.08% |
| 2022 Q4 | 523.04 Million INR | -5.5% |
| 2022 Q3 | 553.45 Million INR | -12.82% |
| 2022 FY | 2.35 Billion INR | -2.75% |
| 2021 Q4 | 491.97 Million INR | -12.52% |
| 2021 FY | 2.42 Billion INR | 61.6% |
| 2021 Q1 | 709.91 Million INR | 81.97% |
| 2021 Q2 | 661.88 Million INR | -6.77% |
| 2021 Q3 | 562.41 Million INR | -15.03% |
| 2020 Q4 | 390.12 Million INR | -9.08% |
| 2020 Q1 | 315.68 Million INR | -13.0% |
| 2020 Q3 | 429.09 Million INR | 17.09% |
| 2020 FY | 1.5 Billion INR | 9.82% |
| 2020 Q2 | 366.46 Million INR | 16.08% |
| 2019 Q3 | 352.51 Million INR | 11.44% |
| 2019 Q1 | 335.5 Million INR | 59.77% |
| 2019 Q4 | 362.83 Million INR | 2.93% |
| 2019 FY | 1.36 Billion INR | 19.68% |
| 2019 Q2 | 316.32 Million INR | -5.72% |
| 2018 Q2 | 311.5 Million INR | -6.58% |
| 2018 FY | 1.14 Billion INR | -16.31% |
| 2018 Q1 | 333.45 Million INR | -10.95% |
| 2018 Q3 | 287.35 Million INR | -7.75% |
| 2018 Q4 | 209.99 Million INR | -26.92% |
| 2017 Q2 | 352.35 Million INR | 8.31% |
| 2017 Q3 | 353.32 Million INR | 0.28% |
| 2017 Q4 | 374.44 Million INR | 5.98% |
| 2017 FY | 1.36 Billion INR | -16.15% |
| 2017 Q1 | 325.31 Million INR | -21.0% |
| 2016 Q1 | 419.58 Million INR | 21.09% |
| 2016 FY | 1.62 Billion INR | 11.92% |
| 2016 Q4 | 411.76 Million INR | 7.09% |
| 2016 Q3 | 384.51 Million INR | -6.68% |
| 2016 Q2 | 412.01 Million INR | -1.8% |
| 2015 Q2 | 394.03 Million INR | 13.36% |
| 2015 Q1 | 347.61 Million INR | 15.49% |
| 2015 FY | 1.45 Billion INR | 32.79% |
| 2015 Q4 | 346.5 Million INR | -5.4% |
| 2015 Q3 | 366.3 Million INR | -7.04% |
| 2014 Q4 | 300.99 Million INR | 44.67% |
| 2014 Q3 | 208.05 Million INR | -24.35% |
| 2014 Q1 | 311.22 Million INR | 0.0% |
| 2014 FY | 1.09 Billion INR | 0.64% |
| 2014 Q2 | 275.02 Million INR | -11.63% |
| 2013 FY | 1.08 Billion INR | 18.5% |
| 2012 Q3 | 53.7 Million INR | -51.75% |
| 2012 Q1 | 71.28 Million INR | 0.0% |
| 2012 FY | 918.39 Million INR | 699.76% |
| 2012 Q4 | 682.11 Million INR | 1170.11% |
| 2012 Q2 | 111.29 Million INR | 56.13% |
| 2011 FY | 114.83 Million INR | -49.65% |
| 2010 FY | 228.09 Million INR | -28.61% |
| 2009 FY | 319.51 Million INR | 382.26% |
| 2008 FY | 66.25 Million INR | -78.84% |
| 2007 FY | 313.14 Million INR | 27.69% |
| 2006 FY | 245.24 Million INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Sigachi Industries Limited | 2 Billion INR | -20.862% |
| Ind-Swift Limited | 2.17 Billion INR | -11.391% |
| Bajaj HealthCare Limited | 1.47 Billion INR | -64.424% |
| Sakar Healthcare Limited | 699.58 Million INR | -245.92% |
| Aurobindo Pharma Limited | 109.54 Billion INR | 97.791% |
| Innova Captab Limited | 3.46 Billion INR | 30.147% |
| Divi's Laboratories Limited | 32.44 Billion INR | 92.54% |
| AstraZeneca Pharma India Limited | 6.22 Billion INR | 61.11% |
| Morepen Laboratories Limited | 6.16 Billion INR | 60.722% |
| Mankind Pharma Limited | 42.19 Billion INR | 94.265% |
| Sequent Scientific Limited | 2.97 Billion INR | 18.757% |
| Wanbury Limited | 1.73 Billion INR | -39.833% |
| Laurus Labs Limited | 15.44 Billion INR | 84.335% |
| Nectar Lifesciences Limited | 4.82 Billion INR | 49.827% |
| Glenmark Life Sciences Limited | 12.43 Billion INR | 80.536% |
| Alembic Limited | 1 Billion INR | -141.975% |
| Hikal Limited | 5.95 Billion INR | 59.382% |
| Alembic Pharmaceuticals Limited | 26.78 Billion INR | 90.964% |
| Neuland Laboratories Limited | 8.24 Billion INR | 70.659% |
| J. B. Chemicals & Pharmaceuticals Limited | 15.25 Billion INR | 84.14% |
| Glenmark Pharmaceuticals Limited | 69.34 Billion INR | 96.51% |
| IOL Chemicals and Pharmaceuticals Limited | 4.71 Billion INR | 48.719% |
| RPG Life Sciences Limited | 2.48 Billion INR | 2.537% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 98.067% |
| Lupin Limited | 125.09 Billion INR | 98.065% |
| Amrutanjan Health Care Limited | 2.09 Billion INR | -15.567% |
| Wockhardt Limited | 7.72 Billion INR | 68.653% |
| Vaishali Pharma Limited | 90.32 Million INR | -2579.281% |
| Aarti Pharmalabs Limited | 5.83 Billion INR | 58.5% |
| Jagsonpal Pharmaceuticals Limited | 652.59 Million INR | -270.831% |
| Jubilant Pharmova Limited | 19.64 Billion INR | 87.68% |
| FDC Limited | 6.58 Billion INR | 63.256% |
| Dr. Reddy's Laboratories Limited | 163.6 Billion INR | 98.521% |
| Kilitch Drugs (India) Limited | 620.47 Million INR | -290.024% |
| Eris Lifesciences Limited | 10.42 Billion INR | 76.79% |
| Venus Remedies Limited | 2.18 Billion INR | -10.878% |
| ZIM Laboratories Limited | 1.26 Billion INR | -90.88% |
| Bliss GVS Pharma Limited | 3.69 Billion INR | 34.514% |
| Par Drugs and Chemicals Limited | 529.13 Million INR | -357.351% |
| Caplin Point Laboratories Limited | 9.2 Billion INR | 73.714% |
| Shilpa Medicare Limited | 3.56 Billion INR | 32.058% |
| Albert David Limited | 1.4 Billion INR | -71.865% |
| Ajanta Pharma Limited | 21.06 Billion INR | 88.511% |
| Hester Biosciences Limited | 1.27 Billion INR | -90.006% |
| Suven Pharmaceuticals Limited | 4.12 Billion INR | 41.309% |
| Solara Active Pharma Sciences Limited | -1.65 Billion INR | 246.145% |
| Gufic Biosciences Limited | 4.07 Billion INR | 40.595% |
| Windlas Biotech Limited | 1.33 Billion INR | -80.759% |
| Procter & Gamble Health Limited | 5.78 Billion INR | 58.142% |
| Aarey Drugs & Pharmaceuticals Limited | 113.02 Million INR | -2041.05% |
| Mangalam Drugs & Organics Limited | 691.19 Million INR | -250.12% |
| Granules India Limited | 16.79 Billion INR | 85.595% |
| Aarti Drugs Limited | 8.31 Billion INR | 70.9% |
| Bal Pharma Limited | 770.19 Million INR | -214.207% |
| Alkem Laboratories Limited | 52.29 Billion INR | 95.373% |
| Sun Pharmaceutical Industries Limited | 258.48 Billion INR | 99.064% |
| Lincoln Pharmaceuticals Limited | 1.88 Billion INR | -28.255% |
| Medicamen Biotech Limited | 495.49 Million INR | -388.402% |
| Unichem Laboratories Limited | 4.86 Billion INR | 50.256% |
| Bafna Pharmaceuticals Limited | 452.15 Million INR | -435.219% |
| Biofil Chemicals and Pharmaceuticals Limited | 12.54 Million INR | -19190.61% |
| Valiant Laboratories Limited | 138.02 Million INR | -1653.26% |
| Orchid Pharma Limited | 2.32 Billion INR | -4.297% |
| Medico Remedies Limited | 262.14 Million INR | -823.159% |
| Ind-Swift Laboratories Limited | 4.13 Billion INR | 41.45% |
| Ipca Laboratories Limited | 48.58 Billion INR | 95.019% |
| Brooks Laboratories Limited | 65.62 Million INR | -3587.911% |
| Syncom Formulations (India) Limited | 559.5 Million INR | -332.528% |
| Piramal Enterprises Limited | 8.04 Billion INR | 69.913% |
| Torrent Pharmaceuticals Limited | 46.75 Billion INR | 94.824% |
| NATCO Pharma Limited | 25.73 Billion INR | 90.597% |
| Suven Life Sciences Limited | -200.79 Million INR | 1305.201% |
| Krebs Biochemicals & Industries Limited | -108.74 Million INR | 2325.355% |
| Strides Pharma Science Limited | 14.38 Billion INR | 83.181% |
| Indoco Remedies Limited | 8.04 Billion INR | 69.912% |
| Alpa Laboratories Limited | 188.89 Million INR | -1181.139% |
| Lasa Supergenerics Limited | 121.02 Million INR | -1899.51% |
| Sun Pharma Advanced Research Company Limited | 391.06 Million INR | -518.823% |